Original article
Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma

https://doi.org/10.1016/0091-6749(91)90208-6Get rights and content

Abstract

Bronchial hyperresponsiveness (BHR) to various stimuli is one of the major clinical features of bronchial asthma. In this study, the effect of a thromboxane A2 (TXA2) receptor antagonist, AA-2414, on BHR to methacholine was evaluated in 15 patients with asthma. The methacholine inhalation test was performed before and after oral administration of AA-2414 for 4 days (20 or 40 mg/day). The provocative concentration of methacholine producing a 20% fall in FEV1 (PC20) was measured as an index of BHR. There was a significant increase in PC20 (p < 0.01) from 0.43 (geometric SEM, 1.42) mg/ml to 0.93 (geometric SEM, 1.43) mg/ml after 40 mg/day of AA-2414, whereas baseline values of FVC and FEV1 were not changed by the treatment. Twenty milligrams per day of AA-2414 did not alter the PC20 value nor the parameter of baseline pulmonary functions. These findings might support our hypothesis that the subthreshold concentration of TXA2 in the bronchial tissues, which has no effect on bronchomotor tone per se, may be involved in BHR in asthma. Further studies with more potent and specific TXA2 receptor antagonists are needed to confirm the conclusion.

References (22)

  • M Fujimura et al.

    Secondary release of thromboxane A2 in aerosol leukotriene C4-induced bronchoconstriction in guinea pigs

    Prostaglandins

    (1988)
  • Cited by (84)

    • Prostanoids

      2009, Asthma and COPD
    • Prostanoids

      2008, Asthma and COPD: Basic Mechanisms and Clinical Management
    • Novel and emerging therapies for asthma

      2005, Drug Discovery Today
      Citation Excerpt :

      Early human studies demonstrated that seratrodast decreased PtdCho20 methacholine [the dose of methacholine that leads to a 20% drop in the forced expiratory volume (FEV)1] significantly after four days of oral administration. However, there was no change in baseline FEV1 and only 15 subjects were studied [10]. Theories on mechanism include a reduction of the number of activated eosinophils infiltrating the airways and releasing proinflammatory cytokines [11,12].

    View all citing articles on Scopus

    Supported in part by Ministry of Education, Science, and Culture Grant 01770510 of Japan.

    View full text